4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-25-000141
CEO sold 5,592 shares at $2.60 ($14,517)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Neill Gilmore Neil CEO | 2025-09-03 | Sale 10b5-1 | −5,592 | $2.60 | $14,517 | 274,690 | D: show line 1 in the form |
| Open-market sales · 5,592 sh · avg $2.60 · $14,517 | |||||||
Loading xslF345X05/wk-form4_1757017197.xml…